CTOs on the Move

TriCore

www.tricore.org

 
TriCore Reference Laboratories is a community-based, independent, clinical reference laboratory that provides full-service, state-of-the-art laboratory tests to health care professionals and their patients. Based in Albuquerque, N.M., with clients in New Mexico and across the US. TriCore offers more than 1,500 laboratory tests ranging from routine (such as cholesterol screens) to highly specialized (such as genetic testing). TriCore participates in scientific research through collaboration with the University of New Mexico and numerous national and international biotech firms.
  • Number of Employees: 1K-5K
  • Annual Revenue: $100-250 Million
  • www.tricore.org
  • 1001 Woodward Place NorthEast
    Albuquerque, NM USA 87102
  • Phone: 505.938.8888

Executives

Name Title Contact Details
Kendra Pesko
Director of Technical Profile
James Brown
Chief Technology Officer Profile
Steve Ayer
Chief Information Officer Profile

Similar Companies

Alzyn

ALZYN is a development stage company pursuing a unique approach to retard the progress of Alzheimer`s Disease. The science originated at the Florida State University`s College of Medicine.

ProMedica Senior Care

ProMedica Senior Care is a leading provider of Skilled Nursing, Outpatient Rehabilitation, Memory Care and Home Health and Hospice Care.

ContraVir Pharmaceuticals, Inc

ContraVir is a biopharmaceutical company focused primarily on the development of drugs to treat herpes zoster, or shingles, which is an infection caused by the reactivation of varicella zoster virus or VZV. Our lead candidate, FV-100, is an orally available nucleoside analogue prodrug of CF-1743 that we are developing for the treatment of shingles. Published preclinical studies demonstrate that FV-100 is significantly more potent against VZV than acyclovir, valacyclovir, and famciclovir, the FDA-approved drugs used for the treatment of shingles. Preclinical studies further demonstrate that FV-100 has a more rapid onset of antiviral activity, and may fully inhibit the replication of VZV more rapidly than these drugs at significantly lower concentration levels. In addition, pharmacokinetic data from completed phase 1 and 2 clinical trials suggest that FV-100 has the potential to demonstrate antiviral activity when dosed orally once-a-day at significantly lower levels than valacyclovir, acyclovir, and famciclovir.

AMD LASERS

AMD LASERS is a Indianapolis, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Infusion Systems

Infusion Systems is a Valencia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.